| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2141.1994.TB05036.X |
| P698 | PubMed publication ID | 7803287 |
| P50 | author | Anna Linda Zignego | Q39507303 |
| P2093 | author name string | Mazzoni A | |
| Ferri C | |||
| Greco F | |||
| Monti M | |||
| Caracciolo F | |||
| La Civita L | |||
| Lombardini F | |||
| Longombardo G | |||
| Capochiani E | |||
| P2860 | cites work | Evolution of tumours and the impact of molecular oncology | Q39494403 |
| Infection of peripheral mononuclear blood cells by hepatitis C virus | Q42982207 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| hepatitis C | Q154869 | ||
| P304 | page(s) | 392-394 | |
| P577 | publication date | 1994-10-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Hepatitis C virus infection in patients with non-Hodgkin's lymphoma | |
| P478 | volume | 88 |
| Q36666226 | A case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology |
| Q51011838 | A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses |
| Q37859853 | Absence of chlamydial infection in Japanese patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue |
| Q48553713 | Achromobacter Infection is Rare in Japanese Patients with Pulmonary B-Cell Lymphoma |
| Q42284167 | An adult patient with respiratory failure and splenomegaly |
| Q27480341 | Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls |
| Q36524424 | Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection |
| Q45749351 | Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course |
| Q41719624 | Autoimmune Phenomena and Hepatitis C Virus in Lymphoproliferative and Connective Tissue Disorders |
| Q27488318 | B-cell clonality in the liver of hepatitis C virus-infected patients |
| Q36441444 | Bilateral Parotid MALToma: a sure shot for radiation |
| Q74566815 | CD56 expression in B-cell lymphoma |
| Q71520637 | Can type C hepatitis infection be complicated by malignant lymphoma? |
| Q43033654 | Characteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients |
| Q39989059 | Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients |
| Q44019710 | Chronic hepatitis C as a risk factor for colorectal adenoma |
| Q37215441 | Chronic hepatitis C in long term survivors of haematological malignancy treated in a single centre |
| Q35960885 | Clinical manifestations of hepatitis C. |
| Q42210964 | Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy |
| Q45755081 | Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. |
| Q27485227 | Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia |
| Q59355453 | Cryoglobulinaemia |
| Q33811619 | Cryoglobulinemia |
| Q33806419 | Cryoglobulinemic vasculitis |
| Q24673191 | Cryoglobulins |
| Q61873087 | Detection of occult low-grade B-cell non-hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia |
| Q26992142 | Direct effects of hepatitis C virus on the lymphoid cells |
| Q41740108 | Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma? |
| Q34294938 | Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection |
| Q92464092 | Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting Antivirals |
| Q36062572 | Establishing the link between hepatitis B virus infection and colorectal adenoma |
| Q27473088 | Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection |
| Q73315124 | Expansion of CD5+ B-cell overexpressing CD81 in HCV infection: towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation |
| Q33715911 | Extrahepatic manifestations of HCV infection: facts and controversies |
| Q45746740 | Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. |
| Q45333951 | Extrahepatic manifestations of hepatitis C among United States male veterans |
| Q36010828 | Extrahepatic manifestations of hepatitis C infection: navigating CHASM. |
| Q45744449 | Feasibility of autologous stem cell transplantation in chronic carriers of hepatitis B and hepatitis C virus |
| Q40135838 | From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals? |
| Q42991985 | Genetic heterogeneity of the hypervariable region I of Hepatitis C virus and lymphoproliferative disorders |
| Q35089842 | HCV Virus and Lymphoid Neoplasms |
| Q42987337 | HCV and HGV in B-cell non-Hodgkin's lymphoma |
| Q38031228 | HCV and Lymphoproliferation |
| Q71061111 | HCV and non-Hodgkin lymphoma |
| Q36971042 | HCV-related autoimmune and neoplastic disorders: the HCV syndrome |
| Q35402136 | Haematopoietic cancer and medical history: a multicentre case control study |
| Q37031355 | Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy |
| Q44010172 | Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study |
| Q27490465 | Hepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb Pathway |
| Q39638643 | Hepatitis C Virus Infection Can Affect Lymphoproliferative Disorders Only as a Cofactor for Epstein-Barr Virus in Liver Transplant Recipients: PTLD.Int Survey |
| Q39639979 | Hepatitis C Virus Inhibits DNA Damage Repair through Reactive Oxygen and Nitrogen Species and by Interfering with the ATM-NBS1/Mre11/Rad50 DNA Repair Pathway in Monocytes and Hepatocytes |
| Q92964678 | Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Nonhomologous End Joining |
| Q37002839 | Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations |
| Q78772221 | Hepatitis C infection and B-cell non-Hodgkin's lymphoma |
| Q73047947 | Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis |
| Q34552105 | Hepatitis C infection and lymphoproliferative disease: accidental comorbidities? |
| Q73189352 | Hepatitis C infection in lymphoma patients in a Turkish center |
| Q40216845 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study. |
| Q35198912 | Hepatitis C virus (HCV) and lymphomagenesis |
| Q40068992 | Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation. |
| Q38244519 | Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment |
| Q26775007 | Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options |
| Q38003148 | Hepatitis C virus cryoglobulinemia and non-hodgkin lymphoma |
| Q42998654 | Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma |
| Q42982075 | Hepatitis C virus in patients with non-Hodgkin's lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients |
| Q37356991 | Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes |
| Q36684233 | Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes |
| Q42991127 | Hepatitis C virus infection and cryoglobulinemia |
| Q95779220 | Hepatitis C virus infection and lymphoma |
| Q45742402 | Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group |
| Q45737062 | Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France |
| Q34070965 | Hepatitis C virus infection and lymphoproliferative disorders |
| Q43048174 | Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma |
| Q22299128 | Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact |
| Q42991870 | Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture |
| Q42989779 | Hepatitis C virus infection-associated non-cryoglobulinaemic monoclonal IgMκ gammopathy responsive to interferon-α treatment |
| Q35237312 | Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer |
| Q36292860 | Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. |
| Q43038855 | Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS. |
| Q33363781 | Hepatitis C virus-associated extrahepatic manifestations: a review |
| Q37371397 | Hepatitis C virus-induced cryoglobulinemia |
| Q34098553 | Hepatitis C virus-related lymphoproliferative disorders: an overview. |
| Q45704529 | Hepatitis C virus: simply too smart to be just a liver pathogen |
| Q27001012 | Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management |
| Q22306040 | Hepatitis C: a review for primary care physicians |
| Q47580213 | Hepatitis C: the complications of immune dysfunction |
| Q34107873 | Hepatitis c and lymphoma |
| Q41519138 | High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. |
| Q73061573 | Histopathological and immunohistochemical study of oral lichen planus-associated HCV infection |
| Q35124736 | Human cell types important for Hepatitis C Virus replication in vivo and in vitro. Old assertions and current evidence |
| Q27491280 | Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders |
| Q27478232 | Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell Lymphoma |
| Q42988876 | Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma. |
| Q43503505 | In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus-associated mixed cryoglobulinemia |
| Q35548868 | Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia |
| Q26770344 | Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy |
| Q89986810 | Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study |
| Q37997024 | Innate immunity and hepatitis C virus infection: a microarray's view |
| Q33616812 | Involvement of DNA damage response pathways in hepatocellular carcinoma |
| Q42985731 | Is Hepatitis C Associated with Non-Hodgkin's Lymphoma? |
| Q45753804 | Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies |
| Q34402277 | Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells |
| Q33588847 | Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis |
| Q34342117 | Lymphotropic HCV strain can infect human primary naïve CD4+ cells and affect their proliferation and IFN-γ secretion activity. |
| Q39094502 | Lymphotropic hepatitis C virus has an interferon‐resistant phenotype |
| Q45766744 | MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha |
| Q74714057 | Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders |
| Q36942539 | Mixed cryoglobulinemia |
| Q33901848 | Mixed cryoglobulinemia: new concepts |
| Q36432725 | Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII). |
| Q42993576 | Multicenter study on hepatitis C virus infection in patients with dilated cardiomyopathy. North Italy Transplant Program (NITP). |
| Q34427560 | Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders |
| Q42992786 | No association between hepatitis C and B-cell lymphoma |
| Q43047776 | No association between lymphoma and hepatitis C virus |
| Q36322056 | Nodal and splenic marginal zone B cell lymphomas |
| Q42980007 | Non-Hodgkin's lymphoma and hepatitis C virus infection |
| Q45509091 | Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection |
| Q35134887 | Oral diseases possibly associated with hepatitis C virus |
| Q40765042 | Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation |
| Q38030534 | Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis |
| Q27480668 | Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection |
| Q35868937 | Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. |
| Q41894042 | Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach |
| Q42982045 | Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders |
| Q43029933 | Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma |
| Q35994869 | Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in South Florida and review of the literature |
| Q34621540 | Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin's lymphoma |
| Q42236858 | Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey |
| Q42999139 | Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma |
| Q45765027 | Primary effusion Burkitt's lymphoma with t(8;22) in a patient with hepatitis C virus-related cirrhosis. |
| Q38565772 | Primary hepatic lymphoma is difficult to discriminate from a liver abscess. |
| Q35206486 | Primary parotid gland lymphoma: a case report |
| Q49806947 | Primary splenic malignant lymphoma mimicking metastasis of rectosigmoid cancer: A case report |
| Q40528517 | Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. |
| Q46650974 | Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia |
| Q41563961 | Pure Red Cell Aplasia Associated With Hepatitis C Infection |
| Q39458017 | Reactivation of epstein–barr virus in B cells of patients with chronic hepatitis C |
| Q55106506 | Recent advances in understanding the biology of marginal zone lymphoma. |
| Q27023448 | Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment |
| Q42986628 | Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas |
| Q41669589 | Review: Hepatitis C virus, autoimmunity and rheumatic disease |
| Q28393906 | Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public |
| Q36167378 | Rituximab-based treatment, HCV replication, and hepatic flares |
| Q36845685 | Role of AID in tumorigenesis |
| Q37224329 | Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation |
| Q73668774 | Sequential development of liver cirrhosis, hepatocellular carcinoma, essential mixed cryoglobulinemia, and non-Hodgkin's lymphoma in a hepatitis C-positive subject |
| Q33346404 | Splenic marginal-zone lymphoma: a distinct clinical and pathological entity |
| Q26746040 | Systemic manifestations of hepatitis C infection |
| Q45744785 | T(14;18) translocation in chronic hepatitis C virus infection |
| Q43035602 | The B-cell receptor of a hepatitis C virus (HCV)–associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis |
| Q35685246 | The Immune Interplay between Thyroid Papillary Carcinoma and Hepatic Fibrosis |
| Q37995199 | The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review |
| Q34308860 | The cryoglobulins: an overview |
| Q43047897 | The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases |
| Q38052844 | The hepatitis C virus infection as a systemic disease |
| Q33392295 | The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results |
| Q35201804 | The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections |
| Q39418450 | The oncologic burden of hepatitis C virus infection: A clinical perspective. |
| Q45759540 | The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis C virus infection |
| Q42984169 | The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association? |
| Q41196091 | Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus. |
| Q54268476 | Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study |
| Q38106958 | Virus-associated lymphomagenesis |
| Q38298448 | Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. |
| Q74042932 | [Hodgkin lymphoma associated with primary Sjögren's syndrome] |
| Q45738841 | bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection |
Search more.